Abbisko Cayman Ltd (2256.HK)
HK$ 6.32
0.32%
+0.02
as of Nov 18, 3:00am EST
Previous Close
HK$ 6.3
Market Cap.
HK$ 4.51B
Volume / 30 day Avg.
2.0M /
2.1M
52 Week High/Low
14.99 / 6.035
PE Ratio(TTM)
—
Dividend Yield
—
Health Care
Biotechnology
Primary exchange: HK
About
Abbisko Medicine Co., Ltd., together with its subsidiaries, engages in the research, discovery, and development of phar… More
Stories
View All >>
The Chinese drug developer stands to receive $20 million plus royalties under a Merck licensing deal after its treatment for a joint disorder was cleared for U…
2026-11-19
BRIEF: Abbisko moves into the black in 2024
2025-01-20